|
Author | Patient Characteristics | Antibodies Used (ATG, ATGAM, or Rituximab) | Indication of Antibodies | Treatment Used | Cause of AKI and Methods | Specific treatment for AKI if Any |
|
Snow et al. [6] | 48-year-old female with CRT | Rabbit-ATG | Induction | Prednisone 60 mg PO/day for 2 days | Unknown | Conservative |
|
Pham et al. [7] | Female with LRT | Rabbit-ATG | Acute Cellular Rejection | TPE 2 treatments | Unknown | Conservative |
|
| 32-year-old male with CRT | Rabbit-ATG | Induction or Acute Cellular Rejection | 1 mg/kg/day oral Prednisone or 2 mg/kg/day for 2 days Followed by TPE 1-2 treatments | Unknown | Conservative |
| 60-year-old male with CRT | ATGAM | Induction or Acute Cellular Rejection | As Above | Unknown | Conservative |
Tanriover et al. [4] | 31-year-old male with CRT | Rabbit-ATG | Induction or Acute Cellular Rejection | As Above | N/A | N/A |
| 41-year-old male with LT | Rabbit-ATG | Induction or Acute Cellular Rejection | As Above | Unknown | Conservative |
| 39-year-old Female with CRT | Rabbit-ATG | Induction or Acute Cellular Rejection | As Above | N/A | N/A |
|
Da Silva et al. [8] | 10-year-old female with aplastic anemia | Rabbit-ATG | Aplastic Anemia | 30 mg/kg/day of Methylprednisone for 3 days followed by prednisone taper | Unknown | Peritoneal Dialysis for 14 days |
|
Boothpur et al. [9] | 24-year-old female with LURT | Rabbit-ATG | Induction | TPE and Methylprednisone 500 mg IV for 2 doses | N/A | N/A |
20-year-old female with LURT | Rabbit-ATG | Induction | TPE 3 treatments | N/A | N/A |
37-year-old male LURT | Rabbit-ATG | Induction | TPE 2 treatments | N/A | N/A |
51-year-old male with LRT | Rabbit-ATG | Induction | Methylprednisone 500 mg IV unknown doses followed by prednisone taper | N/A | N/A |
|
Andresdottir et al. [10] | 51-year-old male with kidney transplant | Horse-ATG | Induction | Unknown | Endocapillary Glomerulonephritis on Kidney biopsy | Conservative |
|
Lundquist et al. [11] | 45-year-old female with Liver Transplant | Rabbit-ATG | Induction | Methylprednisone 250 mg (3 mg/kg/day) 3 doses | Unknown | Conservative |
|
Disperati et al. [12] | 52-year-old female with follicular lymphoma | Rituximab | Stage IV Follicular Lymphoma | IV Methylprednisone of unknown dose | N/A | N/A |
|
DeMonaco and Jacobs [13] | 47-year-old female with follicular lymphoma | Rituximab | Follicular Lymphoma | High dose corticosteroids followed by 10-day prednisone taper that failed. Then unknown doses of prednisone and indomethacin | N/A | N/A |
|
D’Arcy and Mannik [14] | 45-year-old male with refractory autoimmune polyneuropathy | Rituximab | Refractory Autoimmune Polyneuropathy | Pulse corticosteroids of unknown doses | N/A | N/A |
|
Herishanu [15] | 48-year-old female with refractory immune thrombocytopenia | Rituximab | Refractory Immune Thrombocytopenia | Methylprednisone 500 mg IV 2 days | N/A | N/A |
|
Hellerstedt and Ahmed [16] | 23-year-old female with Lupus | Rituximab | Autoimmune Thrombocytopenia | Steroid bolus of unknown doses | N/A | N/A |
|
Todd and Helfgott [1] | 68-year-old male with stage 2A mantle cell lymphoma | Rituximab | Treatment for Mantle Cell Lymphoma | Intra-articular Methylprednisone 80 mg and Oral prednisone 20 mg daily followed by Prednisone taper for 4 weeks | N/A | N/A |
|
Sandhu et al. | 51-year-old male with CRT | Rabbit-ATG and Rituximab | Acute Cellular Rejection | SoluMedrol 500 mg IV 3 days | Acute Tubular Necrosis findings on Urine Microscopy | Conservative |
|